[{"Assets_0_Q1_USD":"7817365000.0","CIK":"872589","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"2.36","EarningsPerShareDiluted_1_Q1_USD":"2.16","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"77738004554.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"355901000.0","NetIncomeLoss_1_Q1_USD":"248931000.0","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","RevenuesConverted_1_Q1_USD":"1318991000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquity_0_Q1_USD":"4866021000.0","Ticker":"REGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"115106000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"105572000.0","filed":"20170504","footnote":null,"form":"10-Q","fp":"Q1","fy":"2017.0","name":"REGENERON PHARMACEUTICALS INC","period":"20170331","qtrs":"0","uom":"USD"}]